
Hexarelin, a synthetic hexapeptide, is gaining attention for its effects on growth hormone release and cardiovascular health. Due to its ability to stimulate the release of growth hormone (GH), accelerate muscle development, and repair while aiding in weight loss, it’s a game changer for many people.
Hexarelin peptide stimulates the release of growth hormones in the brain. Unlike conventional growth hormone therapies, Hexarelin offers a more targeted approach by promoting the natural production of these biologically active substances within the body.
What is Hexarelin?
Hexarelin is a synthetic growth hormone-releasing peptide that offers enhanced stability and potency compared to its natural counterpart, ghrelin. It binds to and activates the growth hormone secretagogue receptor (GHSR) in the brain. [1] However, Hexarelin also exerts direct effects on the cardiovascular system due to the presence of GHSR in the heart and blood vessels. Research indicates that Hexarelin has cardioprotective properties and could be a promising therapeutic agent for certain cardiovascular conditions. [2]
This peptide was first developed in the 1980s aiming to create a growth hormone secretagogue (GHS) that would not inadvertently raise levels of sex hormones, insulin, or glucagon. [1] Scientists discovered that Hexarelin had a longer-lasting effect on pituitary growth hormone stimulation compared to larger related peptides, led to increased body weight in treated rats, and did not cause receptor desensitization. [1]
Recent studies have revealed additional benefits of Hexarelin beyond growth hormone secretion. Research into its neuroprotective properties has shown that Hexarelin reduces brain inflammation, preventing cell damage and death, while also promoting neurogenesis in the hippocampus. [3] Additionally, Hexarelin has demonstrated the ability to protect the heart by enhancing cardiac muscle contraction efficiency, preventing and reversing heart damage from reduced blood flow. [2]

Mechanism of Action
Growth hormone is produced and secreted by the pituitary gland. Hexarelin enhances this process by boosting the signals that stimulate the release of growth hormone. This leads to an increased secretion of growth hormone from the pituitary gland. Additionally, Hexarelin inhibits somatostatin, a hormone that normally reduces the body’s natural growth hormone production. By counteracting somatostatin, Hexarelin significantly increases the levels of growth hormone. [4]
Hexarelin binds to and activates the growth hormone secretagogue receptor in the brain, similar to the natural hormone ghrelin, but it is more potent and stable than ghrelin. Research also suggests that Hexarelin may have additional cardiovascular effects due to the presence of growth hormone secretagogue receptors in the heart and blood vessels, extending its impact beyond just growth hormone release and neuroendocrine functions. [2]
Benefits of Hexarelin
Weight Loss
In addition to its role in stimulating growth hormone release, Hexarelin also enhances fat metabolism through its interaction with the CD36 scavenger receptor. [5] A study found that Hexarelin significantly reduced triglyceride accumulation in these cells by acting on the CD36 receptor. Furthermore, Hexarelin increased gene expression in fat metabolism and boosted ATP-related energy production. Since most body fat is stored in white fat cells, Hexarelin’s impact on lipolysis presents significant potential for weight loss. [6]
Another 2017 study, examined insulin sensitivity in two groups of previously overweight women compared to a control group of women who had never been overweight. [7] Research has shown that Hexarelin can enhance insulin sensitivity, which improves nutrient partitioning. Additionally, Hexarelin is associated with increased lean body mass leading to improved metabolism and body composition in those who use it. [7]
Hearth Health
Historically, exogenous ghrelin has been used to aid recovery in cardiac patients following surgeries and adverse cardiac events. However, ghrelin, a naturally occurring peptide, has limited effectiveness due to its rapid degradation. [8]
In contrast, the synthetic hexapeptide Hexarelin offers greater potency, a longer half-life, and more beneficial cardiac effects than exogenous ghrelin. Hexarelin has shown the potential to enhance long-term cardiac function in patients with chronic heart failure, reverse atherosclerosis, and reduce heart fibrosis and hypertrophy. [2]
Additionally, Hexarelin has been found to reduce atherosclerosis by improving the lipid profile in the circulatory system. It also appears to lessen cardiac fibrosis, characterized by the thickening and scarring of heart tissue, though this has primarily been studied in spontaneously hypertensive rats. This effect is achieved by decreasing collagen synthesis and promoting its degradation through the regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP). [9]
Recovery and Muscle Preservation
As a growth hormone secretagogue, Hexarelin enhances the body’s ability to utilize growth hormone, which aids in the repair of muscles, tendons, and bones after injury or intense exercise. [10] With a quicker recovery from tissue damage, Hexarelin allows people to increase training intensity or volume without experiencing excessive fatigue or muscle damage. Hexarelin’s influence on growth hormone secretion can improve sleep, leading to deeper and more restorative rest. This can improved sleep quality will directly affect strength, recovery time and optimize body composition. [11]
A study conducted in 2017 explored the potential of growth hormone secretagogues to mitigate severe muscle loss. In this study, rats were treated with cisplatin, a chemotherapy drug known to induce muscle wasting and other negative health effects While the cisplatin led to mitochondrial dysfunction and muscle atrophy in the untreated control group, the rats receiving Hexarelin exhibited notable resistance to muscle loss and strength decline. The researchers attributed these protective effects to Hexarelin’s role in enhancing mitochondrial function, reducing inflammation, and regulating cell turnover, thereby helping to preserve muscle mass. [12]
Can Hexarelin Help With Muscle Building?
Current research on Hexarelin and muscle building is limited, but existing studies offer some insights into its effects on growth hormone (GH) release, which might influence muscle growth.
Hexarelin was designed to stimulate GH release and since GH is crucial for muscle development, Hexarelin may have the potential to support muscle growth by increasing GH levels. It’s important to note that the effects of Hexarelin on GH release may diminish with long-term use, which could potentially reduce its effectiveness for sustained muscle growth. With more studies on the way, we will hopefully get better insights into Hexarelin’s use for muscle building. [12]

Side Effects of Hexarelin
Since Hexarelin has not yet undergone large-scale clinical trials, researchers must carefully evaluate all potential risks before proceeding with extensive studies on this compound.
Growth hormone is released into the body in response to Hexarelin stimulation. At higher doses, it can also elevate levels of adrenocorticotropic hormone (ACTH), cortisol, and prolactin, which may increase the risks of hypertension and diabetes. [13]
Chronic hypercortisolism, though rare, can lead to issues such as androgenic hair growth in women, obesity, infertility, and muscle weakness. Similarly, chronic hyperprolactinemia, particularly concerning for men, can result in secondary hypogonadism, leading to decreased male hormone production and issues with libido, mood, and bone density. [14] [15]
Hexarelin is usually administered via subcutaneous injection, which may cause typical injection site issues, such as pain, redness, swelling, bruising, or infection. These side effects can often be minimized by following a well-planned dosing protocol. Another notable issue with Hexarelin is that when taken orally it has a lower bioavailability, which can limit its effectiveness when taken by mouth.
The Dosage
Since Hexarelin is not FDA-approved for human use there are no no official dosage guidelines. However, based on available medical research, a suggested daily dose is between 200 mcg and 300 mcg. The best results are often achieved when Hexarelin is administered subcutaneously 2 to 3 times a day, with each dose being approximately 70-100 mcg.
Smaller, more frequent doses are generally recommended to stimulate the release of growth hormone (GH) at regular intervals, creating a natural rhythm of hormone release. If taken orally, a common regimen involves two tablets daily, each containing around 200 mcg. If the dose is effective, there’s no need to raise it. The goal should always be the smallest effective dose, starting at a low level and increasing gradually.
Closing Thoughts
Although Hexarelin shows potential benefits for growth and muscle building, the evidence supporting its use is limited due to the lack of extensive human studies. It isn’t a cure-all for health or fitness but may offer certain benefits such as stimulation of GH production, improvements in heart health, reduction of body weight, and muscle recovery.
However, there are some concerns with its long-term safety. As research on Hexarelin progresses, it’s best to consult your doctor and figure out if it’s a good option for you. They are able to offer tailored guidance according to your particular requirements and medical conditions.
Sourcing
USA
- LIMITLESS LIFE NOOTROPICS aka Biotech
-
Use Discount Code: EP20
Copied EP20
- SCANTIFIX
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
Canada
Europe
- DNLABResearch
-
Use Discount Code: EP15
Copied EP15
- Crystal Peptides
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
- Particle Peptides
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
Australia
- LVLUPHEALTH
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
- SCANTIFIX
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
References
[1] C. Y. BOWERS, F. A. MOMANY, G. A. REYNOLDS, A. HONG, On the in Vitro and in Vivo Activity of a New Synthetic Hexapeptide that Acts on the Pituitary to Specifically Release Growth Hormone, Endocrinology, Volume 114, Issue 5, 1 May 1984, Pages 1537–1545, https://doi.org/10.1210/endo-114-5-1537
[2] Mao Y, Tokudome T, Kishimoto I. The cardiovascular action of hexarelin. J Geriatr Cardiol. 2014 Sep;11(3):253-8. doi: 10.11909/j.issn.1671-5411.2014.03.007. PMID: 25278975; PMCID: PMC4178518.
[3] McDonald, H., J. Peart, N.D. Kurniawan, G. Galloway, S.G. Royce, C.S. Samuel, and C. Chen. "Hexarelin Targets Neuroinflammatory Pathways to Preserve Cardiac Morphology and Function in a Mouse Model of Myocardial Ischemia-Reperfusion." Biomedicine & Pharmacotherapy, vol. 127, 2020, 110165. ISSN: 0753-3322. DOI: 10.1016/j.biopha.2020.110165.
[4] A. Rahim, P. A. O’Neill, S. M. Shalet, Growth Hormone Status during Long-Term Hexarelin Therapy, The Journal of Clinical Endocrinology & Metabolism, Volume 83, Issue 5, 1 May 1998, Pages 1644–1649, https://doi.org/10.1210/jcem.83.5.4812
[5] Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, Wahli W, Marleau S, Ong H, Tremblay A. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway. Mol Endocrinol. 2006 Dec;20(12):3165-78. doi: 10.1210/me.2006-0146. Epub 2006 Sep 7. PMID: 16959872.
[6] Rodrigue-Way A, Demers A, Ong H, Tremblay A. A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes. Endocrinology. 2007 Mar;148(3):1009-18. doi: 10.1210/en.2006-0975. Epub 2006 Nov 30. PMID: 17138655.
[7] Clamp LD, Hume DJ, Lambert EV, Kroff J. Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history. Nutr Diabetes. 2017 Jun 19;7(6):e282. doi: 10.1038/nutd.2017.31. PMID: 28628125; PMCID: PMC5519190.
[8] Hotta M, Ohwada R, Katakami H, Shibasaki T, Hizuka N, Takano K. Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab. 2004 Nov;89(11):5707-12. doi: 10.1210/jc.2004-0353. PMID: 15531532.
[9] Meanti R, Rizzi L, Bresciani E, Molteni L, Locatelli V, Coco S, Omeljaniuk RJ, Torsello A. Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity. Pharmaceuticals (Basel). 2021 May 8;14(5):444. doi: 10.3390/ph14050444. PMID: 34066741; PMCID: PMC8150489.
[10] Tavares AB, Micmacher E, Biesek S, Assumpção R, Redorat R, Veloso U, Vaisman M, Farinatti PT, Conceição F. Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old. Int J Endocrinol. 2013;2013:942030. doi: 10.1155/2013/942030. Epub 2013 Dec 8. PMID: 24382963; PMCID: PMC3870652.
[11] Frieboes RM, Antonijevic IA, Held K, Murck H, Pollmächer T, Uhr M, Steiger A. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers. Psychoneuroendocrinology. 2004 Aug;29(7):851-60. doi: 10.1016/S0306-4530(03)00152-5. PMID: 15177700.
[12] Ciccarelli E, Grottoli S, Razzore P, Gianotti L, Arvat E, Deghenghi R, Camanni G, Ghigo E. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients. Clin Endocrinol (Oxf). 1996 Jan;44(1):67-71. doi: 10.1046/j.1365-2265.1996.626446.x. PMID: 8706295.
[13] Massoud AF, Hindmarsh PC, Brook CG. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study. J Clin Endocrinol Metab. 1996 Dec;81(12):4338-41. doi: 10.1210/jcem.81.12.8954038. PMID: 8954038.
[14] Thapa S, Bhusal K. Hyperprolactinemia. 2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30726016.
[15] Kumar P, Kumar N, Thakur DS, Patidar A. Male hypogonadism: Symptoms and treatment. J Adv Pharm Technol Res. 2010 Jul;1(3):297-301. doi: 10.4103/0110-5558.72420. PMID: 22247861; PMCID: PMC3255409.


